Immune System Key Overview
Immune System Key (ISK) is engaged in the discovery and development of treatments for malignant cancers and autoimmune diseases, with a primary focus on treating patients with acute myeloid leukemia (AML), pancreatic cancer, and triple-negative breast cancer. Its assets are based on novel human-secreted peptides that were discovered by the company's founders. ISK's lead compound is Nerofe, which offers the potential to inhibit all three biological processes that support cancer progression. In phase-1 testing, researchers demonstrated induction of a strong anti-angiogenic effect and activation of anticancer immune response. In addition, in-vitro experiments indicate that Nerofe may have a strong inhibitory effect on cancer cell proliferation. Nerofe was granted orphan status by the FDA for the treatment of AML. The company has also developed a novel marker whose presence in a patient's biopsy can help predict the success of treatment with Nerofe.
Cumulative Funding Raised Over Time ($)
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $3.7M |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 6 |
| Investors | 1 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | www.immunesk.com |
Locations
Yossele Rosenblatt St 318, Jerusalem
Photos & Videos
1 item(s)
Immune System Key Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcareProvidersCore Technology
BiologicalsMoleculesTags (10)
cancerpharmaceuticalsoncologybiotechnologydrug-discoverypeptidestreatmentsautoimmune-diseaseshealthcare-providershospitalsGeographic Markets
GlobalImmune System Key Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Non-Equity Funding
Immune System Key Lifecycle
Cumulative Funding Raised Over Time
All Events
Immune System Key News
4 articlesImmune System Key Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 12 classification IDs that could be used for matching.
Immune System Key Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | markets, not claimed |
| BI Verification | Sharon Shapira |
| Registrar ID | 513754820 |
| Crunchbase | immune-system-key |
| Phone | +97226751189 |
| Creator | Sharon Shapira |
| Creator email | shapira.sharon2@gmail.com |
| Last updater | Paul Weisko |
| Updater email | pweisko@gmail.com |
| Last update | 2021-04-26T00:00:00.000Z |
| Created | 2014-11-12T00:00:00.000Z |